0

539938

MIL

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

Medico Intercontinental Limite Share Price Today

Investment Returns

Over 1 Month 14.46% Over 3 Months -13.83% Over 6 Months -13.20% Over 1 Year -35.87%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

Medico Intercontinental Limite fundamentals


  • Market cap (Cr) [-]
  • P/E Ratio (TTM) [-]
  • Beta [-]
  • Book Value / share [-]
  • Return on equity [-]%
  • EPS (TTM) [-]
  • Dividend yield [-]%
  • Net profit/quarter (Cr) [-]
info icon alternate text
  • Market cap (Cr) 25.20
  • P/E Ratio (TTM) 11.55
  • Beta 0.40
  • Book Value / share 40.85
  • Return on equity 6.88%
  • EPS (TTM) 2.18
  • Dividend yield [-]%
  • Net profit/quarter (Cr) 0.42
info icon alternate text

Medico Intercontinental Limite Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition
info-icon
Revenue
Net income
Particulars MAR 2026 (Values in Cr)
Revenue 15.82
Operating Expense 15.82
Net Profit 0.42
Net Profit Margin (%) 2.65
Earnings Per Share (EPS) 0.42
EBITDA 1.28
Effective Tax Rate (%) 42.46
Particulars DEC 2025 (Values in Cr)
Revenue 12.75
Operating Expense 12.71
Net Profit 0.61
Net Profit Margin (%) 4.78
Earnings Per Share (EPS) 0.61
EBITDA 1.40
Effective Tax Rate (%) 27.38
Particulars SEP 2025 (Values in Cr)
Revenue 12.42
Operating Expense 12.20
Net Profit 0.59
Net Profit Margin (%) 4.75
Earnings Per Share (EPS) 0.59
EBITDA 1.45
Effective Tax Rate (%) 25.92
Particulars JUN 2025 (Values in Cr)
Revenue 13.47
Operating Expense 12.97
Net Profit 0.56
Net Profit Margin (%) 4.15
Earnings Per Share (EPS) 0.56
EBITDA 1.35
Effective Tax Rate (%) 24.32
Particulars MAR 2025 (Values in Cr)
Revenue 15.24
Operating Expense 14.68
Net Profit 0.53
Net Profit Margin (%) 3.47
Earnings Per Share (EPS) 0.53
EBITDA 1.13
Effective Tax Rate (%) 23.18
Particulars MAR 2026 (Values in Cr)
Revenue 54.46
Operating Expense 53.69
Net Profit 2.18
Net Profit Margin (%) 4.00
Earnings Per Share (EPS) 2.18
EBITDA 5.48
Effective Tax Rate (%) 29.80
Particulars MAR 2025 (Values in Cr)
Revenue 67.13
Operating Expense 64.06
Net Profit 2.57
Net Profit Margin (%) 3.82
Earnings Per Share (EPS) 2.57
EBITDA 4.81
Effective Tax Rate (%) 28.21
Particulars MAR 2024 (Values in Cr)
Revenue 44.04
Operating Expense 41.83
Net Profit 1.90
Net Profit Margin (%) 4.31
Earnings Per Share (EPS) 1.90
EBITDA 3.02
Effective Tax Rate (%) 27.86
Particulars MAR 2023 (Values in Cr)
Revenue 48.88
Operating Expense 46.84
Net Profit 1.70
Net Profit Margin (%) 3.47
Earnings Per Share (EPS) 1.70
EBITDA 2.84
Effective Tax Rate (%) 28.15
Particulars MAR 2022 (Values in Cr)
Revenue 39.25
Operating Expense 37.60
Net Profit 1.31
Net Profit Margin (%) 3.33
Earnings Per Share (EPS) 4.04
EBITDA 2.45
Effective Tax Rate (%) 28.41
Particulars MAR 2025 (Values in Cr)
Book Value / Share 48.65
ROE % 10.80
ROCE % 13.71
Total Debt to Total Equity 0.23
EBITDA Margin 9.14
Particulars MAR 2024 (Values in Cr)
Book Value / Share 45.03
ROE % 9.16
ROCE % 12.37
Total Debt to Total Equity 0.11
EBITDA Margin 8.73
Particulars MAR 2023 (Values in Cr)
Book Value / Share 41.19
ROE % 13.41
ROCE % 16.53
Total Debt to Total Equity 0.25
EBITDA Margin 7.57
Particulars MAR 2022 (Values in Cr)
Book Value / Share 38.89
ROE % 27.95
ROCE % 25.40
Total Debt to Total Equity 0.81
EBITDA Margin 7.16
Particulars MAR 2021 (Values in Cr)
Book Value / Share 29.35
ROE % 32.45
ROCE % 24.80
Total Debt to Total Equity 1.44
EBITDA Margin 7.10
Particulars MAR 2025 (Values in Cr)
Book Value / Share 38.66
ROE % 6.88
ROCE % 9.51
Total Debt to Total Equity 0.19
EBITDA Margin 7.15
Particulars MAR 2024 (Values in Cr)
Book Value / Share 36.10
ROE % 5.40
ROCE % 7.73
Total Debt to Total Equity 0.05
EBITDA Margin 6.86
Particulars MAR 2023 (Values in Cr)
Book Value / Share 34.30
ROE % 8.10
ROCE % 10.86
Total Debt to Total Equity 0.20
EBITDA Margin 5.81
Particulars MAR 2022 (Values in Cr)
Book Value / Share 23.55
ROE % 18.73
ROCE % 18.78
Total Debt to Total Equity 0.79
EBITDA Margin 6.24
Particulars MAR 2021 (Values in Cr)
Book Value / Share 19.51
ROE % 20.89
ROCE % 19.71
Total Debt to Total Equity 1.16
EBITDA Margin 6.09
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 2.68
Total Assets 75.76
Total Liabilities 75.76
Total Equity 48.64
Share Outstanding 1
Price to Book Ratio 0.92
Return on Assets (%) 6.67
Return on Capital (%) 7.71
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 3.36
Total Assets 56.04
Total Liabilities 56.04
Total Equity 45.03
Share Outstanding 1
Price to Book Ratio 1.10
Return on Assets (%) 7.04
Return on Capital (%) 7.91
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 6.78
Total Assets 58.87
Total Liabilities 58.87
Total Equity 41.18
Share Outstanding 1
Price to Book Ratio 2.42
Return on Assets (%) 6.12
Return on Capital (%) 7.86
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 1.86
Total Assets 31.92
Total Liabilities 31.92
Total Equity 12.63
Share Outstanding 0
Price to Book Ratio 2.47
Return on Assets (%) 9.70
Return on Capital (%) 14.57
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.51
Total Assets 30.64
Total Liabilities 30.64
Total Equity 9.53
Share Outstanding 0
Price to Book Ratio 1.31
Return on Assets (%) 8.40
Return on Capital (%) 13.93
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 1.41
Total Assets 58.77
Total Liabilities 58.77
Total Equity 38.66
Share Outstanding 1
Price to Book Ratio 0.92
Return on Assets (%) 4.36
Return on Capital (%) 4.95
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 2.40
Total Assets 39.44
Total Liabilities 39.44
Total Equity 36.09
Share Outstanding 1
Price to Book Ratio 1.10
Return on Assets (%) 4.80
Return on Capital (%) 5.12
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 4.94
Total Assets 44.37
Total Liabilities 44.37
Total Equity 34.29
Share Outstanding 1
Price to Book Ratio 2.42
Return on Assets (%) 3.84
Return on Capital (%) 4.66
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 1.28
Total Assets 17.71
Total Liabilities 17.71
Total Equity 7.65
Share Outstanding 0
Price to Book Ratio 2.47
Return on Assets (%) 7.40
Return on Capital (%) 9.47
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.11
Total Assets 16.42
Total Liabilities 16.42
Total Equity 6.34
Share Outstanding 0
Price to Book Ratio 1.31
Return on Assets (%) 7.27
Return on Capital (%) 10.71
Particulars MAR 2025 (Values in Cr)
Net Income 6.97
Cash from Operations -5.29
Cash from Investing -2.18
Cash from Financing 8.62
Net change in Cash -0.67
Free Cash Flow -3.29
Particulars MAR 2024 (Values in Cr)
Net Income 5.43
Cash from Operations 6.87
Cash from Investing -8.53
Cash from Financing -0.45
Net change in Cash -3.42
Free Cash Flow 8.11
Particulars MAR 2023 (Values in Cr)
Net Income 4.94
Cash from Operations -8.80
Cash from Investing -5.38
Cash from Financing 20.40
Net change in Cash 4.92
Free Cash Flow -8.38
Particulars MAR 2022 (Values in Cr)
Net Income 4.23
Cash from Operations 5.01
Cash from Investing -1.29
Cash from Financing -1.20
Net change in Cash 1.35
Free Cash Flow 5.22
Particulars MAR 2021 (Values in Cr)
Net Income 3.53
Cash from Operations 6.59
Cash from Investing -0.94
Cash from Financing -5.14
Net change in Cash -0.26
Free Cash Flow 6.80
Particulars MAR 2025 (Values in Cr)
Net Income 3.57
Cash from Operations -5.78
Cash from Investing -4.77
Cash from Financing 10.57
Net change in Cash -0.98
Free Cash Flow -3.89
Particulars MAR 2024 (Values in Cr)
Net Income 2.62
Cash from Operations 6.34
Cash from Investing -6.64
Cash from Financing -1.62
Net change in Cash -2.54
Free Cash Flow 6.37
Particulars MAR 2023 (Values in Cr)
Net Income 2.37
Cash from Operations -11.29
Cash from Investing -5.02
Cash from Financing 20.63
Net change in Cash 3.66
Free Cash Flow -10.92
Particulars MAR 2022 (Values in Cr)
Net Income 1.82
Cash from Operations 1.72
Cash from Investing -0.79
Cash from Financing 0.87
Net change in Cash 1.16
Free Cash Flow 1.78
Particulars MAR 2021 (Values in Cr)
Net Income 1.66
Cash from Operations 5.91
Cash from Investing -0.94
Cash from Financing -4.51
Net change in Cash -0.02
Free Cash Flow 6.09
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENT L 31.80 13.14 1.53 243.69 23.12 38.85
BLISS GVS PHARMA LTD. 486.60 39.50 4.32 5160.70 118.35 493.70
CIPLA LTD 1353.85 28.73 3.17 109370.14 1165.55 1672.20
FERMENTA BIOTECH LIMITED 338.20 14.92 2.44 995.36 256.40 399.00
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENT L 31.80 22.24 4.09 243.69 23.12 38.85
AMRUTANJAN HEALTH CARE LTD. 546.70 24.50 4.26 1580.54 490.00 789.95
ASTRAZENECA PHARMA IND LT 8406.60 109.79 24.07 21016.50 7630.00 9850.00
BLISS GVS PHARMA LTD. 486.60 52.49 4.46 5160.70 118.35 493.70

Medico Intercontinental Limite shareholding pattern

Holding
42.85%
57.14%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

Medico Intercontinental Limite Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
25.17 -4.40 redarrow
red-green-graph indicator
11 Bearish
5 Bullish
  • 5 Days 25.80
  • 26 Days 24.70
  • 10 Days 25.40
  • 50 Days 25.50
  • 12 Days 25.30
  • 100 Days 27.80
  • 20 Days 24.80
  • 200 Days 31.30
25.91 PIVOT
First Support 24.92 First Resistance 27.32 Second Support 23.51 Second Resistance 28.31 Third Support 22.52 Third Resistance 29.72
RSI 52.46 ADX 23.84 MACD 0.55 Williams % R -50.00 Commodity Channel Index (CCI) 58.29
Date 2026-06-19 Week 2800.00 Same Day 2096.00 Month 4711.00
1 Year 0.41 3 Year 0.39
Over 1 Month
14.46% down
Over 1 Year
-35.87% down
Over 3 Months
-13.83% down
Over 3 Years
-29.74% down
Over 6 Months
-13.20% down
Over 5 Years
-10.40% down

Medico Intercontinental Limite Corporate Actions

Dividend date Dividend amount Dividend type Record date Instrument type
23 Jun 2023 0.1 Final 23 Jun 2023 Equity shares

Top Gainers

Top Losers

stock
Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Medico Intercontinental Ltd?

Answer Field

Medico Intercontinental Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 25.17 as on Jun 19 2026 03:29 PM.

What is the Market Cap of Medico Intercontinental Ltd Share?

Answer Field

The market cap of Medico Intercontinental Ltd for NSE ₹ 0.00 & for BSE ₹ 25.20 as on Jun 19 2026 03:29 PM.

What is the 52 Week High and Low of Medico Intercontinental Ltd?

Answer Field

The 52 Week High and Low of Medico Intercontinental Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 43.00 and ₹ 20.61.

What is 1 year return for Medico Intercontinental Ltd?

Answer Field

The 1 year returns on the stock has been -35.87%.

What is the P/E Ratio of Medico Intercontinental Ltd Share?

Answer Field

As on Jun 19 2026 03:29 PM the price-to-earnings (PE) ratio for Medico Intercontinental Ltd share is 11.55.

What is the PB ratio of Medico Intercontinental Ltd Share?

Answer Field

As on Jun 19 2026 03:29 PM, the price-to-book (PB) ratio for Medico Intercontinental Ltd share is 40.85.

How to Buy Medico Intercontinental Ltd Share?

Answer Field

You can trade in Medico Intercontinental Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Medico Intercontinental Ltd Share on Bajaj Broking App?

Answer Field

To buy Medico Intercontinental Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Medico Intercontinental Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image
Get Free Demat Account*
+91
close-img
Authorise with OTP
Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|